Skip to main content
. 2024 Oct 23;11:1473196. doi: 10.3389/fnut.2024.1473196

Table 3.

Association between serum vitamin B12 level (pg/mL) and serum α-klotho (pg/mL) levels.

Non-adjusted model Model I Model II Model III
β (95%CI) P-value β (95%CI) P-value β (95%CI) P-value β (95%CI) P-value
Vitamin B12 0.05 (0.03, 0.08) <0.0001 0.05 (0.03, 0.08) <0.0001 0.05 (0.02, 0.07) 0.001 0.02 (−0.00, 0.05) 0.0755
Vitamin B12 quartile
Q1 Reference Reference Reference Reference
Q2 34.17 (11.15, 57.18) 0.0036 34.61 (11.53, 57.69) 0.0033 46.05 (20.62, 71.48) 0.0004 48.71 (23.70, 73.73) 0.0001
Q3 42.42 (19.25, 65.59) 0.0003 43.09 (19.82, 66.36) 0.0003 53.36 (28.11, 78.61) <0.0001 49.14 (24.02, 74.26) 0.0001
Q4 83.65 (59.67, 107.62) <0.0001 84.27 (60.22, 108.31) <0.0001 83.98 (57.98, 109.97) <0.0001 68.90 (42.81, 94.99) <0.0001
P for trend <0.0001 <0.0001 <0.0001 <0.0001

Adjust I model was adjusted for: gender; age, years (smooth); race. Adjust II model was adjusted for: model I + alcohol use; smoking status; sleep disorder; hypertension; diabetes; weak kidneys; asthma; congestive heart failure; coronary heart disease; COPD; thyroid problem; liver condition; stroke; gout; cancer or malignancy; BMI, kg/m2 (Smooth). Generalized additive models were applied. Adjust III model was adjusted for: model II + 25-hydroxyvitamin D3 (smooth); HDL (smooth); triglyceride (smooth); glucose (smooth); HbA1c (smooth); serum urate; eGFR (smooth); AST (smooth); ALT (smooth).